D
U.S. Neurosurgical Holdings, Inc.
USNU
$0.8854
$0.00180.20%
D
Sell
4/12/2024Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 4/12/2024 due to a significant increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.0161 to -$0.0108.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 4/12/2024 due to a significant increase in the total return index, growth index and volatility index. Earnings per share increased from -$0.0161 to -$0.0108.
E
Sell
11/20/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 11/20/2023 due to a decline in the valuation index, growth index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 11/20/2023 due to a decline in the valuation index, growth index and volatility index.
D
Sell
9/18/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 9/18/2023 due to an increase in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 9/18/2023 due to an increase in the volatility index and total return index.
E
Sell
9/1/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 9/1/2023 due to a decline in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 9/1/2023 due to a decline in the volatility index.
D
Sell
8/17/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 8/17/2023 due to an increase in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 8/17/2023 due to an increase in the volatility index and total return index.
E
Sell
8/11/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 8/11/2023 due to a decline in the volatility index and growth index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 8/11/2023 due to a decline in the volatility index and growth index.
D
Sell
7/26/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
E
Sell
7/7/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 7/7/2023 due to a decline in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 7/7/2023 due to a decline in the volatility index.
D
Sell
6/20/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 6/20/2023 due to an increase in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 6/20/2023 due to an increase in the volatility index.
E
Sell
5/31/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 5/31/2023 due to a decline in the volatility index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 5/31/2023 due to a decline in the volatility index and valuation index.
D
Sell
5/19/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 5/19/2023 due to an increase in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 5/19/2023 due to an increase in the volatility index and total return index.
E
Sell
5/2/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 5/2/2023 due to a decline in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 5/2/2023 due to a decline in the volatility index and total return index.
D
Sell
4/17/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 4/17/2023 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0412 to $0.0632, the quick ratio increased from 1.94 to 5.49, and debt to equity declined from 0.05 to 0.02.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 4/17/2023 due to an increase in the growth index, solvency index and volatility index. Earnings per share increased from -$0.0412 to $0.0632, the quick ratio increased from 1.94 to 5.49, and debt to equity declined from 0.05 to 0.02.
E
Sell
3/13/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 3/13/2023 due to a decline in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 3/13/2023 due to a decline in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index and volatility index.
D
Sell
12/28/2022Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D- from D on 12/28/2022 due to a noticeable decline in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D- from D on 12/28/2022 due to a noticeable decline in the volatility index.
D
Sell
11/25/2022Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D from D- on 11/25/2022 due to a noticeable increase in the volatility index, total return index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D from D- on 11/25/2022 due to a noticeable increase in the volatility index, total return index and valuation index.
D
Sell
6/27/2022Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D- from D on 6/27/2022 due to a substantial decline in the total return index, efficiency index and solvency index. The quick ratio declined from 3.48 to 2.66, and total capital declined 16.32% from $3.09M to $2.59M.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D- from D on 6/27/2022 due to a substantial decline in the total return index, efficiency index and solvency index. The quick ratio declined from 3.48 to 2.66, and total capital declined 16.32% from $3.09M to $2.59M.
D
Sell
1/3/2022Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 1/3/2022 due to a decline in the total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 1/3/2022 due to a decline in the total return index.
D
Sell
12/7/2021Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 12/7/2021 due to an increase in the total return index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 12/7/2021 due to an increase in the total return index and volatility index.
D
Sell
11/22/2021Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from C- on 11/22/2021 due to a significant decline in the valuation index, efficiency index and solvency index. The quick ratio declined from 7.7 to 6.13, and total capital declined 9.45% from $3.74M to $3.38M.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from C- on 11/22/2021 due to a significant decline in the valuation index, efficiency index and solvency index. The quick ratio declined from 7.7 to 6.13, and total capital declined 9.45% from $3.74M to $3.38M.
C
Hold
10/7/2021Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 10/7/2021 due to an increase in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 10/7/2021 due to an increase in the volatility index and total return index.
D
Sell
9/22/2021Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C- on 9/22/2021 due to a decline in the total return index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C- on 9/22/2021 due to a decline in the total return index and volatility index.
C
Hold
8/13/2021Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 8/13/2021 due to a substantial decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0692 to -$0.0737, net income declined 206.49% from $539 to -$574, and EBIT declined 136.78% from $677 to -$249.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 8/13/2021 due to a substantial decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.0692 to -$0.0737, net income declined 206.49% from $539 to -$574, and EBIT declined 136.78% from $677 to -$249.
C
Hold
8/5/2021Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 8/5/2021 due to a decline in the total return index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 8/5/2021 due to a decline in the total return index and volatility index.
C
Hold
7/6/2021Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C+ from C on 07/06/2021.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C+ from C on 07/06/2021.
C
Hold
6/7/2021Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 6/7/2021 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 64.03% from $595 to $214, EBIT declined 18.14% from $827 to $677, and total revenue declined 9.16% from $1.17M to $1.06M.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 6/7/2021 due to a large decline in the growth index, total return index and efficiency index. Operating cash flow declined 64.03% from $595 to $214, EBIT declined 18.14% from $827 to $677, and total revenue declined 9.16% from $1.17M to $1.06M.
C
Hold
5/19/2021Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C+ from C on 5/19/2021 due to a substantial increase in the total return index, valuation index and efficiency index. Total capital increased 1.36% from $3.83M to $3.88M.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C+ from C on 5/19/2021 due to a substantial increase in the total return index, valuation index and efficiency index. Total capital increased 1.36% from $3.83M to $3.88M.
C
Hold
7/28/2020Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 7/28/2020 due to an increase in the total return index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 7/28/2020 due to an increase in the total return index and valuation index.
C
Hold
6/24/2020Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 6/24/2020 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0128 to $0.0225, operating cash flow increased 61.37% from $466 to $752, and total revenue increased 0.13% from $746 to $747.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 6/24/2020 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.0128 to $0.0225, operating cash flow increased 61.37% from $466 to $752, and total revenue increased 0.13% from $746 to $747.
D
Sell
4/15/2020Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 4/15/2020 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 235.25% from $139 to $466, EBIT increased 28.42% from $292 to $375, and total revenue increased 13.37% from $658 to $746.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 4/15/2020 due to a significant increase in the valuation index, efficiency index and growth index. Operating cash flow increased 235.25% from $139 to $466, EBIT increased 28.42% from $292 to $375, and total revenue increased 13.37% from $658 to $746.
D
Sell
12/5/2019Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 12/5/2019 due to a decline in the volatility index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 12/5/2019 due to a decline in the volatility index and valuation index.
D
Sell
11/20/2019Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 11/20/2019 due to an increase in the growth index, efficiency index and volatility index. Net income increased 294.92% from -$59 to $115, and earnings per share increased from -$0.0076 to $0.01.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 11/20/2019 due to an increase in the growth index, efficiency index and volatility index. Net income increased 294.92% from -$59 to $115, and earnings per share increased from -$0.0076 to $0.01.
D
Sell
8/19/2019Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 8/19/2019 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.0239 to -$0.0076, net income declined 131.72% from $186 to -$59, and EBIT declined 15.88% from $447 to $376.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 8/19/2019 due to a noticeable decline in the growth index, efficiency index and total return index. Earnings per share declined from $0.0239 to -$0.0076, net income declined 131.72% from $186 to -$59, and EBIT declined 15.88% from $447 to $376.
D
Sell
5/16/2019Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 5/16/2019 due to a noticeable increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0565 to $0.02, EBIT increased 122.39% from $201 to $447, and total revenue increased 32.44% from $635 to $841.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to D+ from D on 5/16/2019 due to a noticeable increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.0565 to $0.02, EBIT increased 122.39% from $201 to $447, and total revenue increased 32.44% from $635 to $841.
D
Sell
4/12/2019Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 4/12/2019 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 266.67% from -$120 to -$440, and total capital declined 12.95% from $6.2M to $5.4M.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D from D+ on 4/12/2019 due to a significant decline in the valuation index, efficiency index and total return index. Net income declined 266.67% from -$120 to -$440, and total capital declined 12.95% from $6.2M to $5.4M.
D
Sell
1/28/2019Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C- on 1/28/2019 due to a decline in the total return index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C- on 1/28/2019 due to a decline in the total return index and volatility index.
C
Hold
1/11/2019Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 1/11/2019 due to an increase in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 1/11/2019 due to an increase in the volatility index and total return index.
D
Sell
12/27/2018Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C- on 12/27/2018 due to a noticeable decline in the volatility index, solvency index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C- on 12/27/2018 due to a noticeable decline in the volatility index, solvency index and total return index.
C
Hold
11/19/2018Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 11/19/2018 due to a large decline in the growth index, valuation index and efficiency index. Net income declined 255.84% from $77 to -$120, earnings per share declined from $0.0099 to -$0.0154, and EBIT declined 91.83% from $355 to $29.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 11/19/2018 due to a large decline in the growth index, valuation index and efficiency index. Net income declined 255.84% from $77 to -$120, earnings per share declined from $0.0099 to -$0.0154, and EBIT declined 91.83% from $355 to $29.
C
Hold
8/16/2018Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 8/16/2018 due to a noticeable increase in the growth index and volatility index. EBIT increased 69.86% from $209 to $355, total revenue increased 29.6% from $865 to $1.12M, and earnings per share increased from $0.008 to $0.0099.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 8/16/2018 due to a noticeable increase in the growth index and volatility index. EBIT increased 69.86% from $209 to $355, total revenue increased 29.6% from $865 to $1.12M, and earnings per share increased from $0.008 to $0.0099.
C
Hold
8/1/2018Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 8/1/2018 due to a decline in the total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 8/1/2018 due to a decline in the total return index.
C
Hold
7/12/2018Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 7/12/2018 due to an increase in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 7/12/2018 due to an increase in the volatility index.
C
Hold
6/27/2018Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 6/27/2018 due to a decline in the total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 6/27/2018 due to a decline in the total return index.
C
Hold
6/11/2018Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 6/11/2018 due to an increase in the total return index, solvency index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 6/11/2018 due to an increase in the total return index, solvency index and volatility index.
C
Hold
5/25/2018Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 5/25/2018 due to a decline in the valuation index, growth index and total return index. Earnings per share declined from $0.019 to $0.008.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C- from C on 5/25/2018 due to a decline in the valuation index, growth index and total return index. Earnings per share declined from $0.019 to $0.008.
C
Hold
9/28/2016Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 9/28/2016 due to a large increase in the efficiency index, total return index and growth index. Operating cash flow increased 45.86% from $604 to $881, and total capital increased 0.16% from $6.08M to $6.09M.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C from C- on 9/28/2016 due to a large increase in the efficiency index, total return index and growth index. Operating cash flow increased 45.86% from $604 to $881, and total capital increased 0.16% from $6.08M to $6.09M.
C
Hold
5/18/2016Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 5/18/2016 due to an increase in the growth index, solvency index and efficiency index. Operating cash flow increased 391.79% from -$207 to $604, EBIT increased 59.68% from $124 to $198, and the quick ratio increased from 1.32 to 1.58.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to C- from D+ on 5/18/2016 due to an increase in the growth index, solvency index and efficiency index. Operating cash flow increased 391.79% from -$207 to $604, EBIT increased 59.68% from $124 to $198, and the quick ratio increased from 1.32 to 1.58.
D
Sell
4/1/2016Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C on 4/1/2016 due to a substantial decline in the growth index, efficiency index and valuation index. Operating cash flow declined 265.6% from $125 to -$207, EBIT declined 25.75% from $167 to $124, and total revenue declined 6.99% from $772 to $718.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to D+ from C on 4/1/2016 due to a substantial decline in the growth index, efficiency index and valuation index. Operating cash flow declined 265.6% from $125 to -$207, EBIT declined 25.75% from $167 to $124, and total revenue declined 6.99% from $772 to $718.
C
Hold
3/11/2016Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from B on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from B on 3/11/2016 due to a significant decline in the volatility index, total return index and valuation index.
B
Buy
2/23/2016Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to B from B+ on 2/23/2016 due to a noticeable decline in the total return index and volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to B from B+ on 2/23/2016 due to a noticeable decline in the total return index and volatility index.
B
Buy
11/17/2015Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B+ from B on 11/17/2015 due to a noticeable increase in the growth index. EBIT increased 247.92% from $48 to $167, earnings per share increased from $0.004 to $0.01, and total revenue increased 14.88% from $672 to $772.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B+ from B on 11/17/2015 due to a noticeable increase in the growth index. EBIT increased 247.92% from $48 to $167, earnings per share increased from $0.004 to $0.01, and total revenue increased 14.88% from $672 to $772.
B
Buy
11/16/2015Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B from C on 11/16/2015 due to a substantial increase in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B from C on 11/16/2015 due to a substantial increase in the volatility index.
C
Hold
11/13/2015Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 11/13/2015 due to a noticeable decline in the volatility index and total return index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 11/13/2015 due to a noticeable decline in the volatility index and total return index.
C
Hold
11/6/2015Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C+ from B on 11/6/2015 due to a large decline in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C+ from B on 11/6/2015 due to a large decline in the volatility index.
B
Buy
10/28/2015Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B from B- on 10/28/2015 due to a large increase in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B from B- on 10/28/2015 due to a large increase in the volatility index.
B
Buy
10/26/2015Upgraded
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B- from C on 10/26/2015 due to a noticeable increase in the volatility index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was upgraded to B- from C on 10/26/2015 due to a noticeable increase in the volatility index and valuation index.
C
Hold
10/22/2015Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 10/22/2015 due to a decline in the volatility index and valuation index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C from C+ on 10/22/2015 due to a decline in the volatility index and valuation index.
C
Hold
10/19/2015Downgrade
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C+ from B- on 10/19/2015 due to a decline in the volatility index.
U.S. Neurosurgical Holdings, Inc. (USNU) was downgraded to C+ from B- on 10/19/2015 due to a decline in the volatility index.
B
Buy
10/2/2015Downgrade
US Neurosurgical Inc. (USNU) was downgraded to B- from B on 10/2/2015 due to a noticeable decline in the volatility index.
US Neurosurgical Inc. (USNU) was downgraded to B- from B on 10/2/2015 due to a noticeable decline in the volatility index.
B
Buy
9/17/2015Upgraded
US Neurosurgical Inc. (USNU) was upgraded to B from C+ on 9/17/2015 due to a large increase in the volatility index and valuation index.
US Neurosurgical Inc. (USNU) was upgraded to B from C+ on 9/17/2015 due to a large increase in the volatility index and valuation index.
C
Hold
9/8/2015Downgrade
US Neurosurgical Inc. (USNU) was downgraded to C+ from B on 9/8/2015 due to a major decline in the volatility index.
US Neurosurgical Inc. (USNU) was downgraded to C+ from B on 9/8/2015 due to a major decline in the volatility index.
B
Buy
8/31/2015Upgraded
US Neurosurgical Inc. (USNU) was upgraded to B from B- on 8/31/2015 due to a large increase in the volatility index and valuation index.
US Neurosurgical Inc. (USNU) was upgraded to B from B- on 8/31/2015 due to a large increase in the volatility index and valuation index.
B
Buy
8/28/2015Upgraded
US Neurosurgical Inc. (USNU) was upgraded to B- from C on 8/28/2015 due to a large increase in the volatility index and valuation index.
US Neurosurgical Inc. (USNU) was upgraded to B- from C on 8/28/2015 due to a large increase in the volatility index and valuation index.
C
Hold
8/24/2015Downgrade
US Neurosurgical Inc. (USNU) was downgraded to C from C+ on 8/24/2015 due to a decline in the volatility index.
US Neurosurgical Inc. (USNU) was downgraded to C from C+ on 8/24/2015 due to a decline in the volatility index.
C
Hold
8/20/2015Downgrade
US Neurosurgical Inc. (USNU) was downgraded to C+ from B- on 8/20/2015 due to a decline in the volatility index.
US Neurosurgical Inc. (USNU) was downgraded to C+ from B- on 8/20/2015 due to a decline in the volatility index.
B
Buy
8/14/2015Downgrade
US Neurosurgical Inc. (USNU) was downgraded to B- from B on 8/14/2015 due to a significant decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.1 to 1.04.
US Neurosurgical Inc. (USNU) was downgraded to B- from B on 8/14/2015 due to a significant decline in the volatility index, total return index and solvency index. The quick ratio declined from 1.1 to 1.04.
B
Buy
4/2/2015Downgrade
US Neurosurgical Inc. (USNU) was downgraded to B from B+ on 4/2/2015 due to a significant decline in the growth index, efficiency index and solvency index. EBIT declined 47.33% from $505 to $266, earnings per share declined from $0.0346 to $0.019, and net income declined 38.89% from $270 to $165.
US Neurosurgical Inc. (USNU) was downgraded to B from B+ on 4/2/2015 due to a significant decline in the growth index, efficiency index and solvency index. EBIT declined 47.33% from $505 to $266, earnings per share declined from $0.0346 to $0.019, and net income declined 38.89% from $270 to $165.
B
Buy
11/14/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to B+ from C on 11/14/2014 due to a significant increase in the valuation index, growth index and volatility index. EBIT increased 125.45% from $224 to $505, total revenue increased 37.86% from $737 to $1.02M, and earnings per share increased from $0.0298 to $0.03.
US Neurosurgical Inc. (USNU) was upgraded to B+ from C on 11/14/2014 due to a significant increase in the valuation index, growth index and volatility index. EBIT increased 125.45% from $224 to $505, total revenue increased 37.86% from $737 to $1.02M, and earnings per share increased from $0.0298 to $0.03.
C
Hold
9/5/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to C from C- on 9/5/2014 due to a large increase in the efficiency index, volatility index and total return index. Total capital increased 200.31% from $2.28M to $6.85M.
US Neurosurgical Inc. (USNU) was upgraded to C from C- on 9/5/2014 due to a large increase in the efficiency index, volatility index and total return index. Total capital increased 200.31% from $2.28M to $6.85M.
C
Hold
6/20/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to C- from D+ on 6/20/2014 due to a large increase in the volatility index.
US Neurosurgical Inc. (USNU) was upgraded to C- from D+ on 6/20/2014 due to a large increase in the volatility index.
D
Sell
6/5/2014Downgrade
US Neurosurgical Inc. (USNU) was downgraded to D+ from C- on 6/5/2014 due to a noticeable decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.37 to 0.76, and the quick ratio declined from 2.55 to 1.38.
US Neurosurgical Inc. (USNU) was downgraded to D+ from C- on 6/5/2014 due to a noticeable decline in the total return index, volatility index and solvency index. Debt to equity increased from 0.37 to 0.76, and the quick ratio declined from 2.55 to 1.38.
C
Hold
4/15/2014Downgrade
US Neurosurgical Inc. (USNU) was downgraded to C- from C+ on 4/15/2014 due to a significant decline in the valuation index, efficiency index and growth index. Operating cash flow declined 80.41% from -$194 to -$38.
US Neurosurgical Inc. (USNU) was downgraded to C- from C+ on 4/15/2014 due to a significant decline in the valuation index, efficiency index and growth index. Operating cash flow declined 80.41% from -$194 to -$38.
C
Hold
4/11/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to C+ from C on 4/11/2014 due to a noticeable increase in the total return index, volatility index and valuation index.
US Neurosurgical Inc. (USNU) was upgraded to C+ from C on 4/11/2014 due to a noticeable increase in the total return index, volatility index and valuation index.
C
Hold
3/24/2014Downgrade
US Neurosurgical Inc. (USNU) was downgraded to C from B- on 3/24/2014 due to a large decline in the volatility index and valuation index.
US Neurosurgical Inc. (USNU) was downgraded to C from B- on 3/24/2014 due to a large decline in the volatility index and valuation index.
B
Buy
3/19/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to B- from C on 3/19/2014 due to a large increase in the volatility index.
US Neurosurgical Inc. (USNU) was upgraded to B- from C on 3/19/2014 due to a large increase in the volatility index.
C
Hold
3/13/2014Downgrade
US Neurosurgical Inc. (USNU) was downgraded to C from B- on 3/13/2014 due to a large decline in the volatility index.
US Neurosurgical Inc. (USNU) was downgraded to C from B- on 3/13/2014 due to a large decline in the volatility index.
B
Buy
3/12/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to B- from C+ on 3/12/2014 due to a noticeable increase in the volatility index.
US Neurosurgical Inc. (USNU) was upgraded to B- from C+ on 3/12/2014 due to a noticeable increase in the volatility index.
C
Hold
3/10/2014Upgraded
US Neurosurgical Inc. (USNU) was upgraded to C+ from C on 3/10/2014 due to a noticeable increase in the valuation index, total return index and volatility index.
US Neurosurgical Inc. (USNU) was upgraded to C+ from C on 3/10/2014 due to a noticeable increase in the valuation index, total return index and volatility index.
OTC PK
03/07/2025 10:12AM Eastern
Quotes delayed
